Top

Published in:

01-08-2014

Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence

Published in: Heart Failure Reviews | Issue 4/2014

Abstract

Our purpose was to determine the test performance characteristics of BNP and NT-proBNP in the diagnosis of heart failure for patients presenting to an emergency department or urgent care center. We searched Medline, Embase, AMED, Cochrane, Cochrane Database of Systematic Reviews, and CINAHL for English-language articles published between 1989 and June 2012. Studies were limited to those using FDA-approved assays. We examined test performance at three pre-specified cutpoints (manufacturers’ suggested, researchers’ optimal, and lowest) and considered the effect of age, gender, ethnicity and renal function. We used the QUADAS—2 tool to examine risk of bias and applicability, and the AHRQ Methods Guide to assess the strength of evidence. Seventy-six articles met our inclusion criteria, 37 examined BNP, 25 examined NT-proBNP, and 14 examined both. Pooled sensitivity and specificity for BNP at the three pre-specified cutpoints were 95, 91, and 95 % (sensitivity) and 55, 80, and 67 % (specificity), respectively. For NT-proBNP, sensitivity and specificity at the same cutpoints were 91, 90, and 96 % (sensitivity) and 67, 74, and 55 % (specificity). Both BNP and NT-proBNP perform well to rule out, but less well to rule in, the diagnosis of heart failure among persons presenting to emergency departments or urgent care centers. Both BNP and NT-proBNP levels are positively associated with age and negatively associated with renal function. However, the effect of these factors with respect to selecting optimal cutpoints is unclear. For BNP, 100 pg/mL appears to be a consensus cutpoint. No clear consensus has emerged for NT-proBNP, but the age-adjusted cutpoints of 450 pg/mL for <50 years, 900 pg/mL for 50–75 years and 1,800 pg/mL for >75 years appear promising and merit greater scrutiny and validation.

Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al (2013) Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 127:e6–e245. doi:10.1161/CIR.0b013e31828124ad

Doust JA, Glasziou PP, Pietrzak E, Dobson AJ (2004) A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 164:1978–1984. doi:10.1001/archinte.164.18.1978

Balion C, Santaguida PL, Hill S, Worster A, McQueen M, Oremus M, McKelvie R, Booker L, Fagbemi J, Reichert S, Raina P (2006) Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. AHRQ, Rockville, MD. AHRQ publication no. 06-E014. Available at: PM:17764210

Trikalinos TA, Balion CM, Coleman CI, Griffith L, Santaguida PL, Vandermeer B et al (2012) Chapter 8: meta-analysis of test performance when there is a “gold standard”. J Gen Intern Med 27:S56–S66. doi:10.1007/s11606-012-2029-1

McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441–1446. doi:10.1056/NEJM197112232852601

Marantz PR, Tobin JN, Wassertheil-Smoller S, Steingart RM, Wexler JP, Budner N et al (1988) The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation 77:607–612PubMedCrossRef

National Clinical Guideline Centre (2010) Chronic heart failure: management of chronic heart failure in adults in primary and secondary care. National Institute for Health and Clinical Excellence, Manchester, UK. NICE Clinical Guideline 108. http://www.nice.org.uk/nicemedia/live/13099/50517/50517.pdf

Chu H, Cole SR (2006) Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J Clin Epidemiol 59:1331–1332. doi:10.1016/j.jclinepi.2006.06.011

Van Houwelingen HC, Arends LR, Stijnen T (2002) Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21:589–624. doi:10.1002/sim.1040

10.

Van Houwelingen HC, Zwinderman KH, Stijnen T (1993) A bivariate approach to meta-analysis. Stat Med 12:2273–2284. doi:10.1002/sim.4780122405

11.

Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58:982–990. doi:10.1016/j.jclinepi.2005.02.022

12.

Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58:882–893. doi:10.1016/j.jclinepi.2005.01.016

13.

The Cochrane Collaboration Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. In: Higgins JP, Green S (eds) The Cochrane Collaboration; 2011. http://www.cochrane-handbook.org/

14.

Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36PubMedCrossRef

15.

Macaskill P (2004) Empirical Bayes estimates generated in a hierarchical summary ROC analysis agreed closely with those of a full Bayesian analysis. J Clin Epidemiol 57:925–932. doi:10.1016/j.jclinepi.2003.12.019

16.

Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536. doi:10.1059/0003-4819-155-8-201110180-00009

17.

Kronick R, Slutsky J, Chang S (eds) (2014) Methods guide for effectiveness and comparative effectiveness reviews. AHRQ publication No. 10(14)-EHC063-EF. Agency for Healthcare Research and Quality, Rockville, MD. http://www.effectivehealthcare.ahrq.gov

18.

Chang SM, Matchar D (eds) (2012) Methods guide for medical test reviews. AHRQ publication No. 12-EC017. Agency for Healthcare Research and Quality, Rockville, MD. http://www.effectivehealthcare.ahrq.gov/reports/final.cfm

19.

Barcarse E, Kazanegra R, Chen A, Chiu A, Clopton P, Maisel A (2004) Combination of B-type natriuretic peptide levels and non-invasive hemodynamic parameters in diagnosing congestive heart failure in the emergency department. Congest Heart Fail 10:171–176. doi:10.1111/j.1527-5299.2004.03308.x

20.

Maisel AS, Clopton P, Krishnaswamy P, Nowak RM, McCord J, Hollander JE et al (2004) Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J 147:1078–1084. doi:10.1016/j.ahj.2004.01.013

21.

Knudsen CW, Riis JS, Finsen AV, Eikvar L, Muller C, Westheim A et al (2004) Diagnostic value of a rapid test for B-type natriuretic peptide in patients presenting with acute dyspnoea: effect of age and gender. Eur J Heart Fail 6:55–62. doi:10.1016/j.ejheart.2003.10.006

22.

Knudsen CW, Omland T, Clopton P, Westheim A, Abraham WT, Storrow AB et al (2004) Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. Am J Med 116:363–368. doi:10.1016/j.amjmed.2003.10.028

23.

Maisel AS, McCord J, Nowak RM, Hollander JE, Wu AH, Duc P et al (2003) Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 41:2010–2017. doi:10.1016/S0735-1097(03)00405-4

24.

McCullough PA, Hollander JE, Nowak RM, Storrow AB, Duc P, Omland T et al (2003) Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med 10:198–204. doi:10.1197/aemj.10.3.198

25.

Villacorta H, Duarte A, Duarte NM, Carrano A, Mesquita ET, Dohmann HJ et al (2002) The role of B-type natriuretic peptide in the diagnosis of congestive heart failure in patients presenting to an emergency department with dyspnea. Arq Bras Cardiol 79:569–572. doi:10.1590/S0066-782X2002001500002

26.

Logeart D, Saudubray C, Beyne P, Thabut G, Ennezat PV, Chavelas C, et al (2002) Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol 40:1794–1800. doi:10.1016/S0735-1097(02)02482-8

27.

McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG et al (2002) B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circ Cardiovasc Qual Outcomes 106:416–422. doi:10.1161/?01.CIR.0000025242.79963.4C

28.

Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161–167. doi:10.1056/NEJMoa020233

29.

Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A (2002) Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39:202–209. doi:10.1016/S0735-1097(01)01744-2

30.

Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L et al (2001) Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 37:379–385. doi:10.1016/S0735-1097(00)01156-6

31.

Wu AH, Omland T, Duc P, McCord J, Nowak RM, Hollander JE et al (2004) The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: an analysis from the Breathing Not Properly Multinational Study. Diabetes Care 27:2398–2404. doi:10.2337/diacare.27.10.2398

32.

Ray P, Arthaud M, Lefort Y, Birolleau S, Beigelman C, Riou B et al (2004) Usefulness of B-type natriuretic peptide in elderly patients with acute dyspnea. Intensive Care Med 30:2230–2236. doi:10.1007/s00134-0042469-0

33.

Choi S, Park D, Lee S, Hong Y, Kim S, Lee J (2007) Cut-off values of B-type natriuretic peptide for the diagnosis of congestive heart failure in patients with dyspnoea visiting emergency departments: a study on Korean patients visiting emergency departments. Emerg Med J 24:343–347. doi:10.1136/emj.2006.041368

34.

Coste J, Jourdain P, Pouchot J (2006) A gray zone assigned to inconclusive results of quantitative diagnostic tests: application to the use of brain natriuretic peptide for diagnosis of heart failure in acute dyspneic patients. Clin Chem 52:2229–2235. doi:10.1373/clinchem.2006.072280

35.

Chung T, Sindone A, Foo F, Dwyer A, Paoloni R, Janu MR et al (2006) Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department. Am Heart J 152:949–955. doi:10.1016/j.ahj.2006.05.020

36.

Collins SP, Lindsell CJ, Peacock WF, Hedger VD, Askew J, Eckert DC et al (2006) The combined utility of an S3 heart sound and B-type natriuretic peptide levels in emergency department patients with dyspnea. J Card Fail 12:286–292. doi:10.1016/j.cardfail.2006.01.012

37.

Daniels LB, Clopton P, Bhalla V, Krishnaswamy P, Nowak RM, McCord J et al (2006) How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J 151:999–1005. doi:10.1016/j.ahj.2005.10.011

38.

Knudsen CW, Omland T, Clopton P, Westheim A, Wu AH, Duc P et al (2005) Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol 46:838–844. doi:10.1016/j.jacc.2005.05.057

39.

Steg PG, Joubin L, McCord J, Abraham WT, Hollander JE, Omland T et al (2005) B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea. Chest 128:21–29. doi:10.1378/chest.128.1.21

40.

Arques S, Roux E, Sbragia P, Pieri B, Gelisse R, Luccioni R et al (2007) Usefulness of bedside tissue Doppler echocardiography and B-type natriuretic peptide (BNP) in differentiating congestive heart failure from noncardiac cause of acute dyspnea in elderly patients with a normal left ventricular ejection fraction and permanent, nonvalvular atrial fibrillation: insights from a prospective, monocenter study. Echocardiography 24:499–507. doi:10.1111/j.1540-8175.2007.00418.x

41.

Wang HK, Tsai MS, Chang JH, Wang TD, Chen WJ, Huang CH (2010) Cardiac ultrasound helps for differentiating the causes of acute dyspnea with available B-type natriuretic peptide tests. Am J Emerg Med 28:987–993. doi:10.1016/j.ajem.2009.05.019

42.

Boldanova T, Noveanu M, Breidthardt T, Potocki M, Reichlin T, Taegtmeyer A et al (2010) Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study. Int J Cardiol 142:265–272. doi:10.1016/j.ijcard.2008.12.214

43.

Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P et al. (2010) Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 55:2062–2076. doi:10.1016/j.jacc.2010.02.025

44.

Lokuge A, Lam L, Cameron P, Krum H, de Villiers S, Bystrzycki A et al (2010) B-type natriuretic peptide testing and the accuracy of heart failure diagnosis in the emergency department. Circulation Heart Failure 3:104–110. doi:10.1161/CIRCHEARTFAILURE.109.869438

45.

Potocki M, Breidthardt T, Reichlin T, Hartwiger S, Morgenthaler NG, Bergmann A et al (2010) Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure. J Intern Med 267:119–129. doi:10.1111/j.1365-2796.2009.02135.x

46.

Kevin Rogers R, Stehlik J, Stoddard GJ, Greene T, Collins SP, Peacock WF et al (2009) Adjusting for clinical covariates improves the ability of B-type natriuretic peptide to distinguish cardiac from non-cardiac dyspnoea: a sub-study of HEARD-IT. Eur J Heart Fail 11:1043–1049. doi:10.1093/eurjhf/hfp127

47.

Pahle AS, Sørli D, Omland T, Knudsen CW, Westheim A, Wu AH et al (2009) Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea. Am J Cardiol 104:966–971. doi:10.1016/j.amjcard.2009.05.039

48.

Dieplinger B, Gegenhuber A, Haltmayer M, Mueller T (2009) Evaluation of novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath. Heart 95:1508–1513. doi:10.1136/hrt.2009.170696

49.

Rogers RK, Stoddard GJ, Greene T, Michaels AD, Fernandez G, Freeman A et al (2009) Usefulness of adjusting for clinical covariates to improve the ability of B-type natriuretic peptide to distinguish cardiac from noncardiac dyspnea. Am J Cardiol 104:689–694. doi:10.1016/j.amjcard.2009.04.043

50.

Noveanu M, Breidthardt T, Cayir S, Potocki M, Laule K, Mueller C (2009) B-type natriuretic peptide-guided management and outcome in patients with obesity and dyspnea—results from the BASEL study. Am Heart J 158:488–495. doi:10.1016/j.ahj.2009.05.033

51.

Gruson D, Thys F, Ketelslegers JM, Pasquet A, Delvau N, Deneys V et al (2009) Multimarker panel in patients admitted to emergency department: a comparison with reference methods. Clin Biochem 42:185–188. doi:10.1016/j.clinbiochem.2008.08.078

52.

Parrinello G, Paterna S, Di Pasquale P, Torres D, Fatta A, Mezzero M et al. (2008) The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. J Card Fail 14:676–686. doi:10.1016/j.cardfail.2008.04.005

53.

Havelka EG, Rzechula KH, Bryant TO, Anneken SM, Kulstad EB (2011) Correlation between impedance cardiography and B-type natriuretic peptide levels in dyspneic patients. J Emerg Med 40:146–150. doi:10.1016/j.jemermed.2008.01.019

54.

Arenja N, Reichlin T, Drexler B, Oshima S, Denhaerynck K, Haaf P et al (2012) Sensitive cardiac troponin in the diagnosis and risk stratification of acute heart failure. J Intern Med 271:598–607. doi:10.1111/j.1365-2796.2011.02469.x

55.

Ro R, Thode HC Jr, Taylor M, Gulla J, Tetrault E, Singer AJ (2011) Comparison of the diagnostic characteristics of two B-type natriuretic peptide point-of-care devices. J Emerg Med 41:661–667. doi:10.1016/j.jemermed.2010.10.025

56.

Bayés-Genis A, Santaló-Bel M, Zapico-Muñiz E, López L, Cotes C, Bellido J et al (2004) N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail 6:301–308. doi:10.1016/j.ejheart.2003.12.013

57.

Moe GW, Howlett J, Januzzi JL, Zowall H, Canadian Multicenter Improved Management of Patients With Congestive Heart Failure (IMPROVE-CHF) Study Investigators (2007) N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation 115:3103–3110. doi:10.1161/CIRCULATIONAHA.106.666255

58.

Bayes-Genis A, Lloyd-Jones DM, van Kimmenade RR, Lainchbury JG, Richards AM, Ordóñnez-Llanos J et al (2007) Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. Arch Intern Med 167:400–407. doi:10.1001/archinte.167.4.400

59.

van Kimmenade RR, Januzzi JL Jr, Ellinor PT, Sharma UC, Bakker JA, Low AF et al (2006) Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol 48:1217–1224. doi:10.1016/j.jacc.2006.03.061

60.

Krauser DG, Chen AA, Tung R, Anwaruddin S, Baggish AL, Januzzi JL Jr (2006) Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. J Card Fail 12:452–457. doi:10.1016/j.cardfail.2006.04.005

61.

Tung RH, Camargo CA Jr, Krauser D, Anwaruddin S, Baggish A, Chen A et al (2006) Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease. Ann Emerg Med 48:66–74. doi:10.1016/j.annemergmed.2005.12.022

62.

Berdagué P, Caffin PY, Barazer I, Vergnes C, Sedighian S, Letrillard S et al (2006) Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients. Am Heart J 151:690–698. doi:10.1016/j.ahj.2005.04.004

63.

Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordóñnez-Llanos J, Santalo-Bel M et al (2006) NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27:330–337. doi:10.1093/eurheartj/ehi631

64.

Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R et al (2006) Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 47:91–97. doi:10.1016/j.jacc.2005.08.051

65.

Zaninotto M, Mion M, Altinier S, Pastorello M, Rocco S, Tosato F et al (2005) NT-proBNP in the differential diagnosis of acute dyspnea in the emergency department. Clin Biochem 38:1041–1044. doi:10.1016/j.clinbiochem.2005.07.010

66.

Sakhuja R, Chen AA, Anwaruddin S, Baggish AL, Januzzi JL Jr (2005) Combined use of amino terminal-pro-brain natriuretic peptide levels and QRS duration to predict left ventricular systolic dysfunction in patients with dyspnea. Am J Cardiol 96:263–266. doi:10.1016/j.amjcard.2005.03.056

67.

Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG et al (2005) The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95:948–954. doi:10.1016/j.amjcard.2004.12.032

68.

Martinez-Rumayor AA, Vazquez J, Rehman SU, Januzzi JL (2010) Relative value of amino-terminal pro-B-type natriuretic peptide testing and radiographic standards for the diagnostic evaluation of heart failure in acutely dyspneic subjects. Biomarkers 15:175–182. doi:10.3109/13547500903411087

69.

Nazerian P, Vanni S, Zanobetti M, Polidori G, Pepe G, Federico R et al (2010) Diagnostic accuracy of emergency Doppler echocardiography for identification of acute left ventricular heart failure in patients with acute dyspnea: comparison with Boston criteria and N-terminal prohormone brain natriuretic peptide. Acad Emerg Med 17:18–26. doi:10.1111/j.1553-2712.2009.00630.x

70.

Steinhart B, Thorpe KE, Bayoumi AM, Moe G, Januzzi JL Jr, Mazer CD (2009) Improving the diagnosis of acute heart failure using a validated prediction model. J Am Coll Cardiol 54:1515–1521. doi:10.1016/j.jacc.2009.05.065

71.

Oh J, Kang SM, Hong N, Choi JW, Lee SH, Park S et al (2009) Relation between red cell distribution width with echocardiographic parameters in patients with acute heart failure. J Card Fail 15:517–522. doi:10.1016/j.cardfail.2009.01.002

72.

Behnes M, Brueckmann M, Ahmad-Nejad P, Lang S, Wolpert C, Elmas E et al (2009) Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema. Int J Cardiol 135:165–174. doi:10.1016/j.ijcard.2008.03.045

73.

Liteplo AS, Marill KA, Villen T, Miller RM, Murray AF, Croft PE et al (2009) Emergency thoracic ultrasound in the differentiation of the etiology of shortness of breath (ETUDES): sonographic B-lines and N-terminal pro-brain-type natriuretic peptide in diagnosing congestive heart failure. Acad Emerg Med 16:201–210. doi:10.1111/j.1553-2712.2008.00347.x

74.

Green SM, Martinez-Rumayor A, Gregory SA, Baggish AL, O’Donoghue ML, Green JA et al (2008) Clinical uncertainty, diagnostic accuracy, and outcomes in emergency department patients presenting with dyspnea. Arch Intern Med 168:741–748. doi:10.1001/archinte.168.7.741

75.

O’Donoghue M, Kenney P, Oestreicher E, Anwaruddin S, Baggish AL, Krauser DG et al (2007) Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study). Am J Cardiol 100:1336–1340. doi:10.1016/j.amjcard.2007.06.020

76.

Robaei D, Koe L, Bais R, Gould I, Stewart T, Tofler GH (2011) Effect of NT-proBNP testing on diagnostic certainty in patients admitted to the emergency department with possible heart failure. Ann Clin Biochem 48:212–217. doi:10.1258/acb.2010.010137

77.

Behnes M, Hoffmann U, Lang S, Weiss C, Ahmad-Nejad P, Neumaier M et al. (2011) Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure. Clin Res Cardiol 100:335–342. doi:10.1007/s00392-010-0248-1

78.

Prosen G, Klemen P, Štrnad M, Grmec S (2011) Combination of lung ultrasound (a comet-tail sign) and N-terminal pro-brain natriuretic peptide in differentiating acute heart failure from chronic obstructive pulmonary disease and asthma as cause of acute dyspnea in prehospital emergency setting. Crit Care 15:R114. doi:10.1186/cc10140

79.

Shaikh K, Ahmad M (2011) Diagnostic significance of NT-proBNP estimation in patients with acute dyspnea. J Coll Physicians Surg Pak 21:584–588. doi:10.2011/JCPSP.584588

80.

Lainchbury JG, Campbell E, Frampton CM, Yandle TG, Nicholls MG, Richards AM (2003) Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 42:728–735. doi:10.1016/S0735-1097(03)00787-3

81.

Sanz MP, Borque L, Rus A, Vicente B, Ramírez Y, Lasa L (2006) Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea. J Clin Lab Anal 20:227–232. doi:10.1002/jcla.20146

82.

Chenevier-Gobeaux C, Claessens YE, Voyer S, Desmoulins D, Ekindjian OG (2005) Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: comparison with brain natriuretic peptide (BNP). Clin Chim Acta 361:167–175. doi:10.1016/j.cccn.2005.05.021

83.

Mueller T, Gegenhuber A, Poelz W, Haltmayer M (2005) Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 91:606–612. doi:10.1136/hrt.2004.037762

84.

Ray P, Arthaud M, Birolleau S, Isnard R, Lefort Y, Boddaert J et al (2005) Comparison of brain natriuretic peptide and probrain natriuretic peptide in the diagnosis of cardiogenic pulmonary edema in patients aged 65 and older. J Am Geriatr Soc 53:643–648. doi:10.1111/j.1532-5415.2005.53213.x

85.

Alibay Y, Beauchet A, El Mahmoud R, Schmitt C, Brun-Ney D, Benoit MO, et al (2005) Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea. Biomed Pharmacother 59:20–24. doi:10.1016/j.biopha.2004.06.002

86.

Gorissen C, Baumgarten R, De Groot M, Van Haren E, Kragten H, Leers M (2007) Analytical and clinical performance of three natriuretic peptide tests in the emergency room. Clin Chem Lab Med 45:678–684. doi:10.1515/CCLM.2007.119

87.

Chenevier-Gobeaux C, Guerin S, Andre S, Ray P, Cynober L, Gestin S et al (2010) Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP. Clin Chem 56:1708–1717. doi:10.1373/clinchem.2010.145417

88.

Shah KB, Kop WJ, Christenson RH, Diercks DB, Kuo D, Henderson S et al (2009) Natriuretic peptides and echocardiography in acute dyspnoea: implication of elevated levels with normal systolic function. Eur J Heart Fail 11:659–667. doi:10.1093/eurjhf/hfp075

89.

Shah KB, Kop WJ, Christenson RH, Diercks DB, Kuo D, Henderson S et al (2009) Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea. Clin Chem 55:59–67. doi:10.1373/clinchem.2008.108159

90.

Gruson D, Rousseau MF, Ahn S, Van Linden F, Thys F, Ketelslegers JM et al (2008) Accuracy of N-terminal-pro-atrial natriuretic peptide in patients admitted to emergency department. Scand J Clin Lab Invest 68:410–414. doi:10.1080/00365510701810605

91.

Chenevier-Gobeaux C, Delerme S, Allo JC, Arthaud M, Claessens YE, Ekindjian OG et al (2008) B-type natriuretic peptides for the diagnosis of congestive heart failure in dyspneic oldest-old patients. Clin Biochem 41:1049–1054. doi:10.1016/j.clinbiochem.2008.05.012

92.

deFilippi CR, Seliger SL, Maynard S, Christenson RH (2007) Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clin Chem 53:1511–1519. doi:10.1373/clinchem.2006.084533

93.

Gruson D, Ketelslegers JM, Verschuren F, Thys F (2012) Head-to-head comparison of the prohormone proBNP1-108 with BNP and Nt-proBNP in patients admitted to emergency department. Clin Biochem 45:249–252. doi:10.1016/j.clinbiochem.2011.12.009

94.

Blatt A, Svirski R, Morawsky G, Uriel N, Neeman O, Sherman D et al (2010) Short and long-term outcome of pregnant women with preexisting dilated cardiomypathy: an NTproBNP and echocardiography-guided study. Isr Med Assoc J 12:613–616PubMed

95.

van Kimmenade RR, Januzzi JL Jr, Bakker JA, Houben AJ, Rennenberg R, Kroon AA et al (2009) Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J Am Coll Cardiol 53:884–890. doi:10.1016/j.jacc.2008.11.032

96.

deFilippi C, van Kimmenade RR, Pinto YM (2008) Amino-terminal pro-B-type natriuretic peptide testing in renal disease. Am J Cardiol 101:82–88. doi:10.1016/j.amjcard.2007.11.029

97.

Chang AM, Maisel AS, Hollander JE (2009) Diagnosis of heart failure. Heart Fail Clin 5:25–35. doi:10.1016/j.hfc.2008.08.013

Title: Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence
Publication date: 01-08-2014
Published in: Heart Failure Reviews / Issue 4/2014
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-014-9447-6

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2014

Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review

A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods

B-type natriuretic peptide-guided therapy: a systematic review

BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review

Incremental predictive value of natriuretic peptides for prognosis in the chronic stable heart failure population: a systematic review

Incremental value of natriuretic peptide measurement in acute decompensated heart failure (ADHF): a systematic review

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page